NL-OMON49550已完成不适用
Innovation of diagnostics and treatment of selective mutism: towards personalized care - Innovation of diagnostics and treatment of selective mutism
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 320
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 至 17（—）
入选标准
- •Eligible for participation in the study of the treatment effectivity are:
- •patients under 18 years, with selective mutism as a primary diagnosis and
- •estimated intelligence above 85 in the patient and parents., Eligible for
- •participation in the healthy control group for the validation study are
- •children between the age of 3 and 18.
排除标准
- •Study of treatment effectivity: Mental retardation in patient and/or parents,
- •inability to read or write Dutch, other primary diagnosis, having had cognitive
- •behavioral therapy for selective mutism in the past year., Validation Study:
- •diagnosis of selective mutism
研究者
相似试验
招募中
不适用
Innovation of diagnostics and treatment of selective mutism: towards personalized careNL-OMON26941Amsterdam UMC320
尚未招募
不适用
Improved diagnostic and therapeutic approaches through the analysis of macrophages on single cell level (SingleMac study)Basic researchDRKS00019188niversitätsklinikum Freiburg500
尚未招募
不适用
Establishment of a novel diagnosis and treatment system of prostate cancer for both early continence recovery and cancer control after radical prostatectomy.prostate cancerJPRN-UMIN000043978Saitama Medical University International Medical Center20
招募中
不适用
Development of new pathological evaluation methods for human lymphedemaJPRN-UMIN000032413Japan Science and Technology Agency100
已完成
不适用
Study for new treatment methods and classifications of severity based on lymph function in patients with lymphedemalymphedemaJPRN-UMIN000009146Yokohama City University Hospital100